Browsing by Keyword : Tetrazoles
Showing results 9 to 20 of 20
Pub Year | | Title | Author(s) |
2017 | | Design and Rationale of the Intima-Medial Thickness Sub-Study of the PreventIon of CArdiovascular Events in iSchemic Stroke Patients with High Risk of Cerebral hemOrrhage (PICASSO-IMT) Study | 이진수 |
2013 | | Effect of cilostazol in acute lacunar infarction based on pulsatility index of transcranial Doppler (ECLIPse): a multicenter, randomized, double-blind, placebo-controlled trial. | 용석우 |
2018 | | Effects of cilostazol and renin-angiotensin system (RAS) blockers on the renal disease progression of Korean patients: a retrospective cohort study | 박인휘 |
2012 | | Efficacy and tolerability of once-daily oral fimasartan 20 to 240 mg/d in Korean Patients with hypertension: findings from Two Phase II, randomized, double-blind, placebo-controlled studies | 신준한 |
2015 | | Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy. | 신준한 |
2016 | | Fimasartan for independent reduction of blood pressure variability in mild-to-moderate hypertension | 강대용 |
2016 | | Hyperuricemia and uncontrolled hypertension in treated hypertensive patients: K-MetS Study | 강대용 |
2019 | | Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study | 박래웅, 윤덕용 |
1998 | | Pharmacokinetics of losartan and its metabolite, EXP3174, after intravenous and oral administration of losartan to rats with streptozotocin-induced diabetes mellitus. | 문창현, 백은주, 이수환, 이희주, 정이숙 |
1999 | | Pharmacological characterization of KR-30988, a novel non-peptide AT1 receptor antagonist, in rat, rabbit and dog. | 이수환, 정이숙 |
2017 | | The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia | 탁승제 |
2015 | | TM-25659-Induced Activation of FGF21 Level Decreases Insulin Resistance and Inflammation in Skeletal Muscle via GCN2 Pathways. | 강엽, 이관우, 전자영, 최성이 |
1